Advertisement
Advertisement
FTLF
FitLife Brands, Inc. Common Stock
6.70
USDSponsored
-0.19
-2.76%
Nov 19, 15:59 UTC -5
Closed
After-Market
6.79
+0.08
+1.27%
FitLife Brands, Inc. Common Stock (FTLF) Earnings
FTLF Earnings Reports
Positive Surprise Ratio
FTLF beat 3 of 9 last estimates.
33%
Next Report
Date of Next Report
Mar 29, 2027
Estimate for Q4 26 (Revenue/ EPS)
$27.76M
/$0.26
Implied change from Q3 26 (Revenue/ EPS)
+8.37%
/+62.50%
Implied change from Q4 25 (Revenue/ EPS)
+7.16%
/+62.50%
FitLife Brands, Inc. Common Stock earnings per share and revenue
On Nov 16, 2026, FTLF reported earnings of 0.16 USD per share (EPS) for Q3 26, missing the estimate of 0.24 USD, resulting in a -34.64% surprise. Revenue reached 25.62 million, compared to an expected 27.34 million, with a -6.28% difference. The market reacted with a -19.46% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.26 USD, with revenue projected to reach 27.76 million USD, implying an increase of 62.50% EPS, and increase of 8.37% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%

Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%

Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%

MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%

Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%

Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-Actual
$0.10
Surprise
-

Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%

Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%

Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%

Agape ATP Corporation Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-Actual
-$0.08
Surprise
-
FAQ
What were FitLife Brands, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, FitLife Brands, Inc. Common Stock reported EPS of $0.16, missing estimates by -34.64%, and revenue of $25.62M, -6.28% below expectations.
How did the market react to FitLife Brands, Inc. Common Stock's Q3 2026 earnings?
The stock price moved down -19.46%, changed from $8.48 before the earnings release to $6.83 the day after.
When is FitLife Brands, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 29, 2027.
What are the forecasts for FitLife Brands, Inc. Common Stock's next earnings report?
Based on --
analysts, FitLife Brands, Inc. Common Stock is expected to report EPS of $0.26 and revenue of $27.76M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.